Looking to leverage this leader’s with 27+ years of experience in the drug evaluation and regulatory submission across all 17 therapeutic areas and recent experience with the Food and Drug Administration providing expert biostatistical guidance on the design, analysis and interpretation of real-world data and real-world evidence, the FDA has identified a leader to support several cross-Agency RWD foundational projects such as Data Catalog and RWD Research Lab.
The post FDA taps first Senior Statistical Advisor in the Office of Information Management and Technology (OIMT) appeared first on G2Xchange Health, a service of MileMarker10.
